Few studies included pre-symptomatic carriers (n = 10 studies, 202 carriers) for selected disorders (FXTAS [14–16], NPC [17], SCA2 [18, 19], SCA3 [20–22] and SCA6 [23]). This evidence concerns the gene CACNA1A and fragile X-associated tremor/ataxia syndrome.